• FirefoxUpgrade to the new Firefox »
  •  Dow Up2.43% Nasdaq Up2.24%

    Celldex Therapeutics, Inc. (CLDX)

    -NasdaqGS
    18.82 0.72(3.95%) Dec 18, 4:00PM EST
    |After Hours : 18.82 0.00 (0.00%) Dec 18, 6:19PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
    Total Revenue 4,111   11,202   9,265  
    Cost of Revenue -   -   -  
    Gross Profit 4,111   11,202   9,265  
    Operating Expenses
    Research Development67,401  47,398  32,439  
    Selling General and Administrative14,805  10,016  9,193  
    Non Recurring2,334  10,775  9,119  
    Others1,013  1,090  1,913  
    Total Operating Expenses85,553  69,279  52,664  
    Operating Income or Loss (81,442) (58,077) (43,399)
    Income from Continuing Operations
    Total Other Income/Expenses Net819  530  396  
    Earnings Before Interest And Taxes(80,623)(57,547)(43,003)
    Interest Expense927  1,576  1,796  
    Income Before Tax(81,550)(59,123)(44,799)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(81,550)(59,123)(44,799)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (81,550) (59,123) (44,799)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (81,550) (59,123) (44,799)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.